Top Markets
#1 Pleasing Gold Pleasing Gold +1,546.27%
#2 PulseChain PulseChain +61.61%
#3 Ontology Gas Ontology Gas +36.94%
#4 DogBull DogBull +36.89%
#5 BOOK OF MEME BOOK OF MEME +30.55%
#6 Neiro Neiro +21.85%
#7 Collect on Fanable Collect on Fanable +21.43%
#8 Nockchain Nockchain +19.56%
#9 Unit Pump Unit Pump +19.14%
#10 Pump.fun Pump.fun +19.14%
Coin of the day
Pleasing Gold Pleasing Gold
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Kedudukan dalam Saham #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Harga Saham
$0.12164306
Disegerakkan terakhir: 2024-11-11
Modal Pasaran
$38.53M
Perubahan (1 hari)
-4.14%
Perubahan (1 tahun)
0.00%
Negara
AU
Perdagangan PharmAust Limited (PAA)

Kategori

Healthcare
Nisbah P/S bagi PharmAust Limited (PAA)
Nisbah P/S pada August 2026 TTM: 0.00
Menurut laporan kewangan dan harga saham terkini PharmAust Limited, nisbah P/S semasa (TTM) ialah 0.00. Pada akhir 2024, nisbah P/S syarikat ialah 0.00.
Sejarah nisbah P/S untuk PharmAust Limited dari 2001 hingga 2026
Nisbah P/S pada akhir setiap tahun
Tahun Nisbah P/S Ubah
2026 (TTM) 0.00 0.00%
2025 0.00 0.00%
2024 0.00 -100.00%
2023 8.53 29.96%
2022 6.56 -51.13%
2021 13.42 -6.50%
2020 14.36 611.37%
2019 2.02 20.63%
2018 1.67 -19.73%
2017 2.08 -15.55%
2016 2.47 -36.92%
2015 3.91 -40.73%
2014 6.60 108.20%
2013 3.17 87.09%
2012 1.70 -67.92%
2011 5.28 -58.41%
2010 12.70 360.27%
2009 2.76 66.79%
2008 1.65 66.92%
2007 0.99 -42.02%
2006 1.71 -41.66%
2005 2.93 -80.04%
2004 14.68 -38.19%
2003 23.75 159.55%
2002 9.15 0.00%
2001 0.00 0.00%
Nisbah P/S untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/S Perbezaan Nisbah P/S Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH